Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$9.99 USD
+0.25 (2.51%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $9.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ORIC 9.99 +0.25(2.51%)
Will ORIC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ORIC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ORIC
Oric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?
Oric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock: Should You Buy?
ORIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy
Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?
What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?
Other News for ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC ...
Oric Pharmaceuticals initiated with bullish view at Ladenburg, here's why
ORIC: New Coverage Initiated with a Buy Rating and $15 Price Target | ORIC Stock News
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC ...
Insider Sell: Dominic Piscitelli Sells 20,000 Shares of ORIC Pharmaceuticals Inc (ORIC)